A randomized controlled trial of interferon-alpha in patients with cirrhosis caused by 2a/2b genotype hepatitis C virus [2]

Journal of Hepatology

Volumn 28, Issue 5, 1998, Pages 910-911

  Ikeda, K ^a   Kumada, H ^a   Saitoh, S ^a   Suzuki, Y ^a   Kobayashi, M ^a   Tsubota, A ^a   Koida, I ^a   Fukuda, M ^a   Arase, Y ^a   Chayama, K ^a   Murashima, N ^a   Tango, T ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LETTER; LIVER CIRRHOSIS; LIVER FUNCTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0031949473     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80244-4     Document Type: Letter

References (11)

1. K Chayama S Saitoh Y Arase K Ikeda T Matsumoto Y Sakai Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C Hepatology 13 1991 1040 1043
2. K Yoshioka S Kakumu H Hayashi T Shinagawa T Wakita T Ishikawa Anti-hepatitis C antibodies in patients with chronic non-A, non-B hepatitis: relation to disease progression and effect of interferon alpha Am J Gastroenterol 86 1991 1495 1499
3. A Tsubota K Chayama K Ikeda Y Arase I Koida S Saitoh Factors predictive of response to inteferon-alpha therapy in hepatitis C virus infection Hepatology 19 1994 1088 1094
4. H Hagiwara N Hayashi E Mita T Takehara A Kasahara H Fusamoto Quantitative analysis of hepatitis C virus RNA in serum during interferon alpha therapy Gastroenterology 104 1993 877 883
5. J Bruix X Calvet J Costa M Ventura M Bruguera R Castillo Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis Lancet ii 1989 1004 1006
6. M Colombo G Kuo QL Choo MF Donato E Del Ninno MA Tommasini Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma Lancet ii 1989 1006 1008
7. F Hasan LJ Jeffers MD Medina KR Reddy T Parker ER Schiff Hepatitis C-associated hepatocellular carcinoma Hepatology 12 1990 589 591
8. MC Kew M Houghton QL Choo G Kuo Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma Lancet 335 1990 873 874
9. K Ikeda S Saitoh I Koida Y Arase A Tsubota K Chayama A multivariate analysis of risk factors for hepatocellular carcinogenesis: a prospective observation of 795 cases with viral and alcoholic cirrhosis Hepatology 18 1993 47 53
10. H Tsukuma T Hiyama S Tanaka M Nakao T Yabuuchi T Kitamura Risk factors for hepatocellular carcinoma among patients with chronic liver disease N Engl J Med 328 1993 1797 1801
11. N Caporaso M Romano R Marmo I de Sio F Morisco A Minerva Hepatitis C virus infection is an additive risk factor for development of hepatocellular carcinoma in patients with cirrhosis J Hepatol 12 1991 367 371